Aug 16 2017 | 6:01pm ET
Mountaingate Capital has raised $395 million in capital commitments for its inaugural lower middle market buyout fund, easily surpassing its $300 million target.
The new fund closed was heavily oversubscribed and closed at its hard cap, the company said in a statement. It will invest in new platform companies and support their efforts with strategic add-on acquisitions in four target sectors: marketing services, business/industrial services, specialty distribution and specialty manufacturing, including medical devices. Three investments have already been made from the fund.
Credit Suisse Securities (USA) LLC acted as exclusive advisor and placement agent for Fund I, while Kirkland & Ellis LLP served as legal counsel.
Based in Denver, CO, Mountaingate Capital was launched in 2017 by a team of partners with deep investment expertise in four distinct market sectors: marketing services, business/industrial services, specialty distribution and specialty manufacturing, including medical devices. The company focuses on companies with $5 million to $25 million of EBITDA enjoying organic growth and couples them with a customer-centric buy-and-build approach for add-on acquisitions.
Jan 30 2018 | 9:49pm ET
As the U.S. shifts from monetary stimulus to fiscal stimulus, market pricing should...
May 24 2017 | 9:25pm ET
Starting in 2019, financial industry executives sitting for the coveted Chartered...
Feb 14 2018 | 9:57pm ET
Tasked with delivering returns on client capital, a common dilemma for many alternative...